Notably, chemotherapy without CD47 blocking strategy enhances CD47 expression on tumor cells via inducing IL-18 release from macrophages, which increases L-amino acid transporter 2 (LAT2) in tumor cells [160]. This evidence concerns the gene LAT2 and neoplasm.